Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
PLoS One
2018 Jan 01;137:e0201210. doi: 10.1371/journal.pone.0201210.
Show Gene links
Show Anatomy links
Expression and purification of a functional heteromeric GABAA receptor for structural studies.
Claxton DP
,
Gouaux E
.
???displayArticle.abstract???
The GABA-gated chloride channels of the Cys-loop receptor family, known as GABAA receptors, function as the primary gatekeepers of fast inhibitory neurotransmission in the central nervous system. Formed by the pentameric arrangement of five identical or homologous subunits, GABAA receptor subtypes are defined by the subunit composition that shape ion channel properties. An understanding of the structural basis of distinct receptor properties has been hindered by the absence of high resolution structural information for heteromeric assemblies. Robust heterologous expression and purification protocols of high expressing receptor constructs are vital for structural studies. Here, we describe a unique approach to screen for well-behaving and functional GABAA receptor subunit assemblies by using the Xenopus oocyte as an expression host in combination with fluorescence detection size exclusion chromatography (FSEC). To detect receptor expression, GFP fusions were introduced into the α1 subunit isoform. In contrast to expression of α1 alone, co-expression with the β subunit promoted formation of monodisperse assemblies. Mutagenesis experiments suggest that the α and β subunits can tolerate large truncations in the non-conserved M3/M4 cytoplasmic loop without compromising oligomeric assembly or GABA-gated channel activity, although removal of N-linked glycosylation sites is negatively correlated with expression level. Additionally, we report methods to improve GABAA receptor expression in mammalian cell culture that employ recombinant baculovirus transduction. From these methods we have identified a well-behaving minimal functional construct for the α1/β1 GABAA receptor subtype that can be purified in milligram quantities while retaining high affinity agonist binding activity.
???displayArticle.pubmedLink???
30028870
???displayArticle.pmcLink???PMC6054424 ???displayArticle.link???PLoS One ???displayArticle.grants???[+]
Fig 1. Expression of GluClα-EGFP in oocytes.(A) Cartoon design of EGFP fusion to the M3/M4 loop of GluClα. (B) Four days after injecting 50 ng of synthetic mRNA, receptor expression is visualized by EGFP fluorescence at the oocyte surface by confocal microscopy. (C) Detergent (C12M) solubilization of oocytes and FSEC analysis on a Superose6 size exclusion column captures a monodisperse elution profile consistent with a pentameric assembly. Arrows indicate peak elution times for ferritin (440 kDa) and EGFP (27 kDa) standards. Receptor expression levels are sensitive to the total concentration of mRNA injected. FSEC traces were acquired from the same batch of oocytes. Absolute fluorescence intensities are shown.
Fig 2. Expression of GABAA receptors in oocytes.(A) The α1/β2 receptor demonstrates increased expression levels and homogeneity relative to the α1 subunit alone. The arrow indicates a population reduction of smaller oligomers in the presence of the β2 subunit. (B) Co-injection of γ2S mRNA with the α1 subunit does not improve receptor homogeneity. (C) Injection of all three subunits results in attenuated expression levels relative to α1/β2. All FSEC traces were acquired from the same batch of oocytes. Absolute fluorescence intensities are plotted on the same scale.
Fig 3. Investigation of α1 and β2 subunit association in oocytes through FRET.Photobleaching of EGFP fused to the α1 subunit results in increased β2-mKalama fluorescence at the oocyte surface relative to a control region, indicating that the subunits are in close enough proximity for subunit fluorescent proteins to undergo FRET.
Fig 4. Truncation of the M3/M4 loop does not perturb receptor assembly or function in oocytes.(A) Cartoon of subunit construct design for α1 and β2 subunits shows locations for GFPuv fusion and loop truncation. A polypeptide linker (red line) connects GFPuv to the N-terminus of the α1 subunit. (B) Expression of GFPuv-α1/β2 increases receptor homogeneity relative to α1-EGFP/β2. However, an increase in cleaved GFPuv fluorescence signal is observed (arrow). (C) Replacement of the native M3/M4 loop in both subunits with a tri-peptide induces a right shift in the elution profile, consistent with a smaller hydrodynamic radius. Absolute fluorescence intensities are shown on the same scale. The FSEC traces shown in (B) and (C) were obtained from the same batch of oocytes. (D) Two-electrode voltage clamp of GFPuv-α1-LT/β2-LT demonstrating that the receptor retains gating activity and sensitivity to zinc.
Fig 5. Removal of glycosylation sites on the N-terminus reduces α1/β2 expression in oocytes.(A) Sequence alignment of the N-terminus for GABAA and GluClα subunits identifying residues for deletion (red line) and predicted sites for glycosylation (*). The red bar represents the first predicted α-helix in the extracellular domain. A blue box outlines the predicted signal peptide. GluClαcryst is the sequence used to obtain the crystal structure. (B) Sequence alignment of the C-terminus for GABAA and GluClα subunits identifying residues for deletion (red line). (C) Removal of an 11-residue tail from the α1 subunit in the GFPuv-α1-LT/β2-LT construct (Fig 4) does not change receptor behavior. (D) Deletion of the N-terminus (ΔN) in either α1 or β2 subunit reduces receptor expression in the α1-EGFP/β2 construct. (E) Site directed mutagenesis of predicted glycosylation sites reduces α1-EGFP/β2 receptor expression. Absolute fluorescence intensities are shown on the same scale. FSEC traces shown in (D) and (E) were obtained from the same batch of oocytes.
Fig 6. Mutation of other predicted glycosylation sites in the β2 subunit alters receptor expression and assembly in oocytes.(A) Site directed mutation of consensus glycosylation sites in the β2 subunit alters receptor expression and monodispersity, which is in contrast to mutation of a second predicted glycosylation site in the α1subunit (B). Absolute fluorescence intensities are shown on the same scale. FSEC traces were obtained from the same batch of oocytes.
Fig 7. The α1-EGFP/β2 receptor cannot be solubilized by detergent from Sf9 cells.(A) Diagram of insect cell expression vectors harboring one (pFastBac1) or both (pFastBac Dual) full-length GABAA subunits. EGFP has been placed in the M3/M4 loop of the α1 subunit. (B) EGFP fluorescence is observed 48 hours post infection for pFastBac1 or pFastBac Dual constructs, suggesting receptor targeting to the cell membrane. (C) FSEC analysis at the indicated time points to measure expression suggests that most of the receptor breaks down upon whole cell solubilization with C12M detergent. (D) FSEC profiles do not improve using the bicistronic pFastBac Dual vector, which ensures each cell possesses a copy of both subunits. Absolute fluorescence intensities for (C) and (D) are shown on the same scale.
Fig 8. Identification of α1-EGFP/β2 receptor expression parameters in mammalian cells.(A) Diagram of pEG BacMam vector used for generating recombinant baculovirus to infect mammalian cells. (B) Addition of 10 mM sodium butyrate to the virus-transduced culture increases receptor yield but induces aggregation. Absolute fluorescence intensities are shown. (C) Infecting cells with a relative MOI ≥ 1 (β:α) increases receptor monodispersity. Area-normalized traces are shown. Cells were grown at 37°C for FSEC traces in (B) and (C). (D) Dropping the temperature of infected cells increases receptor yield and reduces aggregation observed at higher temperatures. Absolute fluorescence intensities are shown in (D).
Fig 9. Optimized mammalian expression parameters apply to other receptor GABAA receptor subtypes.(A) A boost in ρ1-EGFP expression levels is observed at 30°C with addition of 10 mM sodium butyrate. (B) Similar to oocytes, the β subunit is required to form a homogeneous receptor in mammalian cells. In addition, the α1-EGFP/β1-LT receptor demonstrates higher expression levels than the α1-EGFP/β2-LT receptor. Expression for each experiment was performed at 30°C. For comparison, the fluorescence scale in (B) is approximately 2-fold greater than in (A). (C) Time course of α1-EGFP/β1-LT expression at 30°C (relative MOI = 0.6, α1:β1) followed by EGFP-FSEC suggests that the receptor demonstrates peak expression levels 60–72 hours post infection. (D) The α1-LT/β1-LT receptor displays GABA-gated current in oocytes by TEVC measurement.
Fig 10. Purification and characterization of the α1/β1 receptor from mammalian cells.(A) Preparative size exclusion chromatography of IMAC-purified material isolates homogeneous receptor as suggested by FSEC analysis of four representative elution fractions collected across the SEC peak (B). (C) SDS-PAGE analysis of SEC fractions across the elution peak shown in (A) indicates diffuse subunit bands, consistent with glycosylation. (D) Purified receptor shows specific binding in C12M or L-MNG detergent. Ligand binding experiments by SPA reveal high affinity binding sites for 3H-muscimol (KD = 24 nM, Bmax = 1690 CPM or 0.76 pmol ligand, E) or GABA (Ki = 98 nM, F) as measured by a direct binding isotherm or competition assay, respectively.
Allen,
De novo mutations in epileptic encephalopathies.
2013, Pubmed
Allen,
De novo mutations in epileptic encephalopathies.
2013,
Pubmed
Althoff,
X-ray structures of GluCl in apo states reveal a gating mechanism of Cys-loop receptors.
2014,
Pubmed
Amin,
GABAA receptor needs two homologous domains of the beta-subunit for activation by GABA but not by pentobarbital.
1993,
Pubmed
,
Xenbase
Anderson,
Drug treatment of REM sleep behavior disorder: the use of drug therapies other than clonazepam.
2009,
Pubmed
Andréll,
Overexpression of membrane proteins in mammalian cells for structural studies.
2013,
Pubmed
Angelotti,
Assembly of GABAA receptor subunits: alpha 1 beta 1 and alpha 1 beta 1 gamma 2S subunits produce unique ion channels with dissimilar single-channel properties.
1993,
Pubmed
Ashikawa,
GFP-based evaluation system of recombinant expression through the secretory pathway in insect cells and its application to the extracellular domains of class C GPCRs.
2011,
Pubmed
Baconguis,
Structural plasticity and dynamic selectivity of acid-sensing ion channel-spider toxin complexes.
2012,
Pubmed
Ban,
The role of serendipity in drug discovery.
2006,
Pubmed
Baulac,
First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene.
2001,
Pubmed
,
Xenbase
Baumann,
Forced subunit assembly in alpha1beta2gamma2 GABAA receptors. Insight into the absolute arrangement.
2002,
Pubmed
,
Xenbase
Baumann,
Subunit arrangement of gamma-aminobutyric acid type A receptors.
2001,
Pubmed
,
Xenbase
Belelli,
Neurosteroids: endogenous regulators of the GABA(A) receptor.
2005,
Pubmed
Birnir,
A combination of human alpha 1 and beta 1 subunits is required for formation of detectable GABA-activated chloride channels in Sf9 cells.
1992,
Pubmed
Bocquet,
X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation.
2009,
Pubmed
Bollan,
GABA(A) receptor composition is determined by distinct assembly signals within alpha and beta subunits.
2003,
Pubmed
Buller,
Site-directed mutagenesis of N-linked glycosylation sites on the gamma-aminobutyric acid type A receptor alpha 1 subunit.
1994,
Pubmed
,
Xenbase
Campagna-Slater,
Molecular modelling of the GABAA ion channel protein.
2007,
Pubmed
Carter,
Functional expression of GABAA chloride channels and benzodiazepine binding sites in baculovirus infected insect cells.
1992,
Pubmed
Casalotti,
Separate subunits for agonist and benzodiazepine binding in the gamma-aminobutyric acidA receptor oligomer.
1986,
Pubmed
Cederholm,
Gating mechanisms in Cys-loop receptors.
2009,
Pubmed
Chang,
Stoichiometry of a recombinant GABAA receptor.
1996,
Pubmed
,
Xenbase
Chen,
GABAA receptor associated proteins: a key factor regulating GABAA receptor function.
2007,
Pubmed
Coleman,
X-ray structures and mechanism of the human serotonin transporter.
2016,
Pubmed
Connolly,
Assembly and cell surface expression of heteromeric and homomeric gamma-aminobutyric acid type A receptors.
1996,
Pubmed
,
Xenbase
Connor,
A GABAA receptor alpha1 subunit tagged with green fluorescent protein requires a beta subunit for functional surface expression.
1998,
Pubmed
,
Xenbase
Crameri,
Improved green fluorescent protein by molecular evolution using DNA shuffling.
1996,
Pubmed
Dibbens,
The role of neuronal GABA(A) receptor subunit mutations in idiopathic generalized epilepsies.
2009,
Pubmed
,
Xenbase
Dostalova,
High-level expression and purification of Cys-loop ligand-gated ion channels in a tetracycline-inducible stable mammalian cell line: GABAA and serotonin receptors.
2010,
Pubmed
Draguhn,
Functional and molecular distinction between recombinant rat GABAA receptor subtypes by Zn2+.
1990,
Pubmed
Du,
Glycine receptor mechanism elucidated by electron cryo-microscopy.
2015,
Pubmed
Dukkipati,
BacMam system for high-level expression of recombinant soluble and membrane glycoproteins for structural studies.
2008,
Pubmed
Ernst,
Comparative models of GABAA receptor extracellular and transmembrane domains: important insights in pharmacology and function.
2005,
Pubmed
Farrar,
Stoichiometry of a ligand-gated ion channel determined by fluorescence energy transfer.
1999,
Pubmed
Ferris,
Evaluation of the Virus Counter® for rapid baculovirus quantitation.
2011,
Pubmed
Franks,
General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal.
2008,
Pubmed
Fukuda,
Folding of green fluorescent protein and the cycle3 mutant.
2000,
Pubmed
Gensler,
Assembly and clustering of acetylcholine receptors containing GFP-tagged epsilon or gamma subunits: selective targeting to the neuromuscular junction in vivo.
2001,
Pubmed
,
Xenbase
Goehring,
Screening and large-scale expression of membrane proteins in mammalian cells for structural studies.
2014,
Pubmed
Gurdon,
Use of frog eggs and oocytes for the study of messenger RNA and its translation in living cells.
1971,
Pubmed
,
Xenbase
Hibbs,
Principles of activation and permeation in an anion-selective Cys-loop receptor.
2011,
Pubmed
Hilf,
X-ray structure of a prokaryotic pentameric ligand-gated ion channel.
2008,
Pubmed
Hilf,
Structure of a potentially open state of a proton-activated pentameric ligand-gated ion channel.
2009,
Pubmed
Hopkins,
A rapid method for titrating baculovirus stocks using the Sf-9 Easy Titer cell line.
2009,
Pubmed
Hosie,
Zinc-mediated inhibition of GABA(A) receptors: discrete binding sites underlie subtype specificity.
2003,
Pubmed
Hsu,
Investigation of optimal transduction conditions for baculovirus-mediated gene delivery into mammalian cells.
2004,
Pubmed
Jansen,
Modular design of Cys-loop ligand-gated ion channels: functional 5-HT3 and GABA rho1 receptors lacking the large cytoplasmic M3M4 loop.
2008,
Pubmed
,
Xenbase
Kawate,
Fluorescence-detection size-exclusion chromatography for precrystallization screening of integral membrane proteins.
2006,
Pubmed
Lee,
NMDA receptor structures reveal subunit arrangement and pore architecture.
2014,
Pubmed
,
Xenbase
Li,
Selective elimination of glutamate activation and introduction of fluorescent proteins into a Caenorhabditis elegans chloride channel.
2002,
Pubmed
,
Xenbase
Lo,
Glycosylation of {beta}2 subunits regulates GABAA receptor biogenesis and channel gating.
2010,
Pubmed
Luckow,
Baculovirus systems for the expression of human gene products.
1993,
Pubmed
Macdonald,
GABA(A) receptor epilepsy mutations.
2004,
Pubmed
Mansoor,
X-ray structures define human P2X(3) receptor gating cycle and antagonist action.
2016,
Pubmed
Miller,
Crystal structure of a human GABAA receptor.
2014,
Pubmed
Miller,
Structural basis for GABAA receptor potentiation by neurosteroids.
2017,
Pubmed
Mitte,
A meta-analytic review of the efficacy of drug treatment in generalized anxiety disorder.
2005,
Pubmed
O'Toole,
Discrete M3-M4 intracellular loop subdomains control specific aspects of γ-aminobutyric acid type A receptor function.
2011,
Pubmed
Olsen,
GABA A receptors: subtypes provide diversity of function and pharmacology.
2009,
Pubmed
Palermo,
Production of analytical quantities of recombinant proteins in Chinese hamster ovary cells using sodium butyrate to elevate gene expression.
1991,
Pubmed
Penmatsa,
X-ray structure of dopamine transporter elucidates antidepressant mechanism.
2013,
Pubmed
Petersen,
SignalP 4.0: discriminating signal peptides from transmembrane regions.
2011,
Pubmed
Pregenzer,
Comparison of interactions of [3H]muscimol, t-butylbicyclophosphoro[35S]thionate, and [3H]flunitrazepam with cloned gamma-aminobutyric acidA receptors of the alpha 1 beta 2 and alpha 1 beta 2 gamma 2 subtypes.
1993,
Pubmed
Pritchett,
Transient expression shows ligand gating and allosteric potentiation of GABAA receptor subunits.
1988,
Pubmed
Pritchett,
Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology.
1989,
Pubmed
Puthenkalam,
Structural Studies of GABAA Receptor Binding Sites: Which Experimental Structure Tells us What?
2016,
Pubmed
Reeves,
Expression and purification of rhodopsin and its mutants from stable mammalian cell lines: application to NMR studies.
1999,
Pubmed
Reeves,
Structure and function in rhodopsin: a tetracycline-inducible system in stable mammalian cell lines for high-level expression of opsin mutants.
2002,
Pubmed
Reeves,
Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line.
2002,
Pubmed
Riss,
Benzodiazepines in epilepsy: pharmacology and pharmacokinetics.
2008,
Pubmed
Rost,
The PredictProtein server.
2004,
Pubmed
Sieghart,
Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes.
1995,
Pubmed
Sigel,
Structure, function, and modulation of GABA(A) receptors.
2012,
Pubmed
Smart,
Differential effect of zinc on the vertebrate GABAA-receptor complex.
1990,
Pubmed
Smart,
GABAA receptors are differentially sensitive to zinc: dependence on subunit composition.
1991,
Pubmed
Smart,
Synaptic neurotransmitter-gated receptors.
2012,
Pubmed
Tan,
Hooked on benzodiazepines: GABAA receptor subtypes and addiction.
2011,
Pubmed
Tierney,
Effects of mutating leucine to threonine in the M2 segment of alpha1 and beta1 subunits of GABAA alpha1beta1 receptors.
1996,
Pubmed
Tretter,
Stoichiometry and assembly of a recombinant GABAA receptor subtype.
1997,
Pubmed
Unwin,
Refined structure of the nicotinic acetylcholine receptor at 4A resolution.
2005,
Pubmed
Vijayan,
Modeling the closed and open state conformations of the GABA(A) ion channel--plausible structural insights for channel gating.
2012,
Pubmed
Walsh,
Structural principles of distinct assemblies of the human α4β2 nicotinic receptor.
2018,
Pubmed
Weber,
Ion currents of Xenopus laevis oocytes: state of the art.
1999,
Pubmed
,
Xenbase
Westbrook,
Micromolar concentrations of Zn2+ antagonize NMDA and GABA responses of hippocampal neurons.
,
Pubmed
Wilkins,
Protein identification and analysis tools in the ExPASy server.
1999,
Pubmed
Wulhfard,
Mild hypothermia improves transient gene expression yields several fold in Chinese hamster ovary cells.
2008,
Pubmed
Xie,
Molecular dynamics investigation of Cl(-) transport through the closed and open states of the 2α12β2γ2 GABA(A) receptor.
2013,
Pubmed
Yoder,
Gating mechanisms of acid-sensing ion channels.
2018,
Pubmed